BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29327715)

  • 21. Challenging Diagnosis of Pure Erythroid Leukemia: A Case Report and Literature Review.
    Sato S; Kobayashi M; Suzaki K; Nanke I; Kosugi N
    Hematol Rep; 2022 Mar; 14(1):38-44. PubMed ID: 35323178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rare type of acute leukemia in peripheral blood smear.
    Suárez EU; Cortti MJ; de Ozaeta CS
    Hematol Transfus Cell Ther; 2023; 45(2):278-279. PubMed ID: 35110002
    [No Abstract]   [Full Text] [Related]  

  • 23. Pure erythroid leukemia.
    Forest M; Roy SF; Houde M; Maietta A
    Clin Case Rep; 2020 Dec; 8(12):3598-3599. PubMed ID: 33363996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pure erythroid leukemia.
    Chen JC; Lee WY; Schaefer JK; Bixby DL
    Clin Case Rep; 2020 Nov; 8(11):2286-2288. PubMed ID: 33235778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea.
    Yadav DK; Paul T; Alhamar M; Inamdar K; Guo Y
    Case Rep Oncol; 2020; 13(2):857-862. PubMed ID: 32884531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern.
    Berger G; Gerritsen M; Yi G; Koorenhof-Scheele TN; Kroeze LI; Stevens-Kroef M; Yoshida K; Shiraishi Y; van den Berg E; Schepers H; Huls G; Mulder AB; Ogawa S; Martens JHA; Jansen JH; Vellenga E
    Blood Adv; 2019 Oct; 3(20):3111-3122. PubMed ID: 31648334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.
    Reinig EF; Greipp PT; Chiu A; Howard MT; Reichard KK
    Mod Pathol; 2018 May; 31(5):705-717. PubMed ID: 29327715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
    Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
    Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythroleukemia: a need for a new definition.
    Park S; Picard F; Dreyfus F
    Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
    Reichard KK; Tefferi A; Abdelmagid M; Orazi A; Alexandres C; Haack J; Greipp PT
    Blood Cancer J; 2022 Nov; 12(11):147. PubMed ID: 36323674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.
    Sun J; Konoplev SN; Wang X; Cui W; Chen SS; Medeiros LJ; Lin P
    Mod Pathol; 2011 Mar; 24(3):384-9. PubMed ID: 21113141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome.
    Park DC; Ozkaya N; Lovitch SB
    Histopathology; 2017 Aug; 71(2):316-321. PubMed ID: 28261852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More than 1
    Montalban-Bravo G; Benton CB; Wang SA; Ravandi F; Kadia T; Cortes J; Daver N; Takahashi K; DiNardo C; Jabbour E; Borthakur G; Konopleva M; Pierce S; Bueso-Ramos C; Patel K; Kornblau S; Kantarjian H; Young KH; Garcia-Manero G; Andreeff M
    Blood; 2017 May; 129(18):2584-2587. PubMed ID: 28246192
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.